KAREN L. KATEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

HOME DEPOT, INC.

Filing Date Source Excerpt
2016-04-04 Ms. Katen enhances our Board’s understanding of international, supply chain and marketing matters, with her expertise in those areas gained through her career at Pfizer Inc., a global pharmaceutical company. ... Each non-employee director who was a Board member during Fiscal 2015 received an annual retainer of $280,000 as of the date of the 2015 annual meeting, other than F. Duane Ackerman, who retired upon the expiration of his term at the 2015 annual meeting. The retainer was paid in the following manner: $230,000 in the form of deferred shares granted under the Omnibus Plan; and $50,000 in the form of cash or deferred stock units under the Directors Plan, at the election of the director.
2017-04-03 Ms. Katen enhances our Board's understanding of international, supply chain and marketing matters, with her expertise in those areas gained through her long and successful career at Pfizer and experience with other healthcare-related organizations.

Data sourced from SEC filings. Last updated: 2025-08-30